According to the experimental results in the control mice, the MMP probe can be activated by gastric dysplasia and adenocarcinoma, and the cathepsin probe can be activated by hyperplastic and dysplastic lesions and adenocarcinoma, demonstrating the feasibility of improving clinical gastric tumor detection [62]. Here, CTSS is linked to adenocarcinoma.